Conference Summary
For nearly 10 years, this conference has brought together academic and commercial scientists with an interest in beta-arrestins, G protein-coupled receptor (GPCR) kinases (GRKs), and related drug development.
This year’s conference will discuss the central role GRKs and arrestins play in the regulation of GPCRs, which regulate nearly every aspect of human physiology and are a target of over 30% of FDA-approved drugs. The program seeks to share research about GRKs and arrestins and how they regulate receptor desensitization, signaling, trafficking, and degradation, little of which is fully understood, particularly the regulation of endocytosis and nuclear activities. There is a significant drive in the scientific community, particularly within academia and the pharmaceutical industry, to understand how GRKs and arrestin function at the molecular, cellular, and physiological levels. Topics will range from the fundamental mechanisms underlying their activity to their physiology and drug development.
This conference will provide opportunities for scientists, particularly early-career researchers, to improve their skills and facilitate networking to develop their scientific careers. There will also be a focus on providing opportunities for researchers from historically excluded groups.
Attendees will learn about:
· Structural and biochemical mechanisms that underly GRK and arrestin activity
· New paradigms for spatiotemporal aspects of GRK and arrestin function
· The physiology of GRK/arrestins and drug development across multiple disease states
Program Topics
· G protein-coupled receptor kinase and arrestin structure and function
· Mechanistic insights into GRK and arrestin dynamics and signaling
· Novel aspects of GRK and arrestin function
· Spatiotemporal aspects of GRK and arrestin function
· Arrestin And arrestin-Like proteins in GPCR trafficking and signaling
· New insights Into GRK, beta-arrestins and arrestin-like proteins
· GRKs and arrestins in cardiovascular and pulmonary diseases
· GRKs and arrestins in obesity / metabolic disease
· GRKs and arrestins in immuno-oncology
· GRKs and arrestins in neurologic and psychiatric diseases
Workshops
Meet the Expert sessions and Career Development Workshops will be offering early-career researchers a chance to interact with the diverse pool of speakers and senior scientists in a roundtable format to receive valuable mentorship, scientific advice, and connections for new career opportunities.
Keynote Speakers


John Tesmer, PhD
Walther Distinguished Professor in Cancer Structural Biology
Purdue University
Lafayette, IN
Learn more
Mark Von Zastrow, MD, PhD
Professor of Psychiatry and Pharmacology
University of California
San Francisco, CA
Learn more
Location and Venue
Niagara Falls Convention Center
Important Dates
Abstract Submission Deadline: Sunday, April 27, 2025
Early Registration Deadline: Monday, June 2, 2025
Housing Deadline: Sunday, June 8, 2025
Registration Cancellation Deadline: Monday, June 2, 2025
Regular Registration Deadline: Sunday, June 15, 2025
Conference Organizers
Davide Calebiro, MD PhD DSc
Chair Of Molecular Endocrinology & Director
Centre of Membrane Proteins and Receptors
University of Birmingham, Birmingham, England
Learn more

Irene Coin, PhD
Full Professor of Synthetic Biochemistry
University of Leipzig, Leipzig, Germany
Learn more

Primary Organizer: Sudarshan Rajagopal MD, PhD
Associate Professor of Medicine
Duke University School of Medicine, Durham, NC
Learn more

JoAnn Trejo, PhD
Professor of Pharmacology
University of California, San Diego, CA
Learn more

